Published in J Clin Invest on November 17, 2005
Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev (2006) 4.46
Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation (2011) 3.81
Association between cell-free hemoglobin, acetaminophen, and mortality in patients with sepsis: an observational study. Crit Care Med (2013) 3.30
Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood (2007) 2.30
Mortality increases after massive exchange transfusion with older stored blood in canines with experimental pneumonia. Blood (2012) 2.22
Hemoglobin-driven pathophysiology is an in vivo consequence of the red blood cell storage lesion that can be attenuated in guinea pigs by haptoglobin therapy. J Clin Invest (2012) 2.19
Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood (2012) 2.10
Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease. Blood (2013) 2.05
Relationship of cell-free hemoglobin to impaired endothelial nitric oxide bioavailability and perfusion in severe falciparum malaria. J Infect Dis (2009) 1.86
Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs. J Clin Invest (2009) 1.77
Storage lesion: role of red blood cell breakdown. Transfusion (2011) 1.74
Hospitalization for pain in patients with sickle cell disease treated with sildenafil for elevated TRV and low exercise capacity. Blood (2011) 1.64
Inhaled nitric oxide enables artificial blood transfusion without hypertension. Circulation (2008) 1.60
Heme degradation and vascular injury. Antioxid Redox Signal (2010) 1.48
Computation of plasma hemoglobin nitric oxide scavenging in hemolytic anemias. Free Radic Biol Med (2006) 1.36
Cerebrovascular disease associated with sickle cell pulmonary hypertension. Am J Hematol (2006) 1.35
Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease. Br J Haematol (2006) 1.34
Increased pulmonary pressures and myocardial wall stress in children with severe malaria. J Infect Dis (2010) 1.33
Pulmonary hypertension and NO in sickle cell. Blood (2010) 1.28
Chronic transfusion therapy improves but does not normalize systemic and pulmonary vasculopathy in sickle cell disease. Blood (2015) 1.25
Diabetes augments and inhaled nitric oxide prevents the adverse hemodynamic effects of transfusing syngeneic stored blood in mice. Transfusion (2012) 1.24
Inhaled NO as a therapeutic agent. Cardiovasc Res (2007) 1.23
Mechanisms of slower nitric oxide uptake by red blood cells and other hemoglobin-containing vesicles. J Biol Chem (2011) 1.21
Pulmonary hypertension in sickle cell disease: relevance to children. Pediatr Hematol Oncol (2007) 1.21
Cell-free hemoglobin and its scavenger proteins: new disease models leading the way to targeted therapies. Cold Spring Harb Perspect Med (2013) 1.18
Pulmonary hypertension in lambs transfused with stored blood is prevented by breathing nitric oxide. Anesthesiology (2012) 1.18
Blood transfusions increase circulating plasma free hemoglobin levels and plasma nitric oxide consumption: a prospective observational pilot study. Crit Care (2012) 1.16
Hemolysis and cell-free hemoglobin drive an intrinsic mechanism for human disease. J Clin Invest (2012) 1.15
Inhaled nitric oxide attenuates the adverse effects of transfusing stored syngeneic erythrocytes in mice with endothelial dysfunction after hemorrhagic shock. Anesthesiology (2012) 1.15
Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia. Br J Haematol (2013) 1.14
Sickle cell disease and nitric oxide: a paradigm shift? Int J Biochem Cell Biol (2006) 1.13
Haptoglobin, hemopexin, and related defense pathways-basic science, clinical perspectives, and drug development. Front Physiol (2014) 1.10
Randomized, placebo-controlled trial of acetaminophen for the reduction of oxidative injury in severe sepsis: the Acetaminophen for the Reduction of Oxidative Injury in Severe Sepsis trial. Crit Care Med (2015) 1.10
Association between haptoglobin, hemopexin and mortality in adults with sepsis. Crit Care (2013) 1.09
Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. Br J Haematol (2008) 1.08
Circulating blood endothelial nitric oxide synthase contributes to the regulation of systemic blood pressure and nitrite homeostasis. Arterioscler Thromb Vasc Biol (2013) 1.04
Autologous transfusion of stored red blood cells increases pulmonary artery pressure. Am J Respir Crit Care Med (2014) 1.02
Reversal of hemoglobin-induced vasoconstriction with sustained release of nitric oxide. Am J Physiol Heart Circ Physiol (2010) 1.02
Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy. JAMA (2008) 1.02
Deconstructing endothelial dysfunction: soluble guanylyl cyclase oxidation and the NO resistance syndrome. J Clin Invest (2006) 1.01
Does prolonged storage of red blood cells cause harm? Br J Haematol (2014) 0.97
Green tea supplementation increases glutathione and plasma antioxidant capacity in adults with the metabolic syndrome. Nutr Res (2013) 0.97
Haptoglobin halts hemoglobin's havoc. J Clin Invest (2009) 0.96
Transfusion of older stored blood worsens outcomes in canines depending on the presence and severity of pneumonia. Transfusion (2014) 0.95
Hemoglobin-based red blood cell substitutes and nitric oxide. Trends Cardiovasc Med (2009) 0.94
Inhaled nitrite reverses hemolysis-induced pulmonary vasoconstriction in newborn lambs without blood participation. Circulation (2011) 0.92
Prevention of the pulmonary vasoconstrictor effects of HBOC-201 in awake lambs by continuously breathing nitric oxide. Anesthesiology (2009) 0.92
Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis. Am J Physiol Heart Circ Physiol (2008) 0.91
Vascular endothelial dysfunction in β-thalassemia occurs despite increased eNOS expression and preserved vascular smooth muscle cell reactivity to NO. PLoS One (2012) 0.89
Haptoglobin Preserves Vascular Nitric Oxide Signaling during Hemolysis. Am J Respir Crit Care Med (2016) 0.88
Hemoglobin-mediated nitric oxide signaling. Free Radic Biol Med (2013) 0.88
Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens! Haematologica (2008) 0.87
Free hemoglobin induction of pulmonary vascular disease: evidence for an inflammatory mechanism. Am J Physiol Lung Cell Mol Physiol (2012) 0.86
Examining and mitigating acellular hemoglobin vasoactivity. Antioxid Redox Signal (2012) 0.83
Pharmacologic strategies for combating the inflammatory response. J Extra Corpor Technol (2007) 0.82
The potential of Angeli's salt to decrease nitric oxide scavenging by plasma hemoglobin. Free Radic Biol Med (2008) 0.82
Red blood cell endothelial nitric oxide synthase does not modulate red blood cell storage hemolysis. Transfusion (2012) 0.82
Angeli's salt counteracts the vasoactive effects of elevated plasma hemoglobin. Free Radic Biol Med (2012) 0.81
What is old is new again: acetaminophen as a novel approach to treating sepsis. Crit Care Med (2015) 0.81
Elevated pulse pressure is associated with hemolysis, proteinuria and chronic kidney disease in sickle cell disease. PLoS One (2014) 0.81
Shiga toxin-1 affects nitric oxide production by human glomerular endothelial and mesangial cells. Pediatr Nephrol (2006) 0.80
Elevation of plasma cell-free hemoglobin in pulmonary arterial hypertension. Chest (2014) 0.80
Effects of a single sickling event on the mechanical fragility of sickle cell trait erythrocytes. Hemoglobin (2010) 0.79
Optimization of the perfusion circuit and its possible impact on the inflammatory response. J Extra Corpor Technol (2007) 0.79
Association between hemoglobin level and endothelial function in uncomplicated, untreated hypertensive patients. Clin J Am Soc Nephrol (2010) 0.79
Substance P is increased in patients with sickle cell disease and associated with haemolysis and hydroxycarbamide use. Br J Haematol (2016) 0.79
Intravascular hemolysis and the pathophysiology of sickle cell disease. J Clin Invest (2017) 0.78
Low micromolar intravascular cell-free hemoglobin concentration affects vascular NO bioavailability in sickle cell disease: a computational analysis. J Appl Physiol (1985) (2012) 0.78
Hemoglobin binding to A beta and HBG2 SNP association suggest a role in Alzheimer's disease. Neurobiol Aging (2006) 0.78
Leukocyte expression of heme oxygenase-1 [hmox1] varies inversely with severity of tricuspid regurgitation in acute pulmonary embolism. Thromb Res (2015) 0.77
Inhaled Nitric Oxide as an Adjunctive Treatment for Cerebral Malaria in Children: A Phase II Randomized Open-Label Clinical Trial. Open Forum Infect Dis (2015) 0.77
Angiotensin-converting enzyme inhibitor captopril reverses the adverse cardiovascular effects of polymerized hemoglobin. Antioxid Redox Signal (2014) 0.77
The Human Endogenous Protection System against Cell-Free Hemoglobin and Heme Is Overwhelmed in Preeclampsia and Provides Potential Biomarkers and Clinical Indicators. PLoS One (2015) 0.76
Cell-free plasma hemoglobin removal by dialyzers with various permeability profiles. Sci Rep (2015) 0.75
In vivo reduction of cell-free methemoglobin to oxyhemoglobin results in vasoconstriction in canines. Transfusion (2013) 0.75
Quality Assessment of Established and Emerging Blood Components for Transfusion. J Blood Transfus (2016) 0.75
Hemolysis results in impaired intestinal microcirculation and intestinal epithelial cell injury. World J Gastroenterol (2011) 0.75
Pulmonary hypertension in hemolytic anemias. F1000 Med Rep (2010) 0.75
Neither a nitric oxide donor nor potassium channel blockage inhibit RBC mechanical damage induced by a roller pump. Open Biomed Eng J (2008) 0.75
Hemolysis-Associated Nitric Oxide Dysregulation during Extracorporeal Membrane Oxygenation. J Extra Corpor Technol (2014) 0.75
Peroxisome Proliferator-Activated Receptor γ Regulates the V-Ets Avian Erythroblastosis Virus E26 Oncogene Homolog 1/microRNA-27a Axis to Reduce Endothelin-1 and Endothelial Dysfunction in the Sickle Cell Mouse Lung. Am J Respir Cell Mol Biol (2017) 0.75
Xenotransfusion of anemic cats with blood compatibility issues: pre- and posttransfusion laboratory diagnostic and crossmatching studies. Vet Clin Pathol (2016) 0.75
Exposure of Stored Packed Erythrocytes to Nitric Oxide Prevents Transfusion-associated Pulmonary Hypertension. Anesthesiology (2016) 0.75
Transfusion related morbidity in premature babies: Possible mechanisms and implications for practice. World J Clin Pediatr (2014) 0.75
Association between alcohol-induced erythrocyte membrane alterations and hemolysis in chronic alcoholics. J Clin Biochem Nutr (2016) 0.75
The neonatal circuit: in search of the ultimate solution. J Extra Corpor Technol (2012) 0.75
Mechanical blood trauma in assisted circulation: sublethal RBC damage preceding hemolysis. Int J Artif Organs (2016) 0.75
Cell-Free Plasma Hemoglobin and Male Gender Are Risk Factors for Acute Kidney Injury in Low Risk Children Undergoing Cardiopulmonary Bypass. Crit Care Med (2017) 0.75
The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature (1980) 40.02
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature (1987) 35.44
Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature (1988) 18.41
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A (1987) 14.22
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med (2002) 7.59
Hemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med (2003) 4.98
Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical. Circ Res (1987) 4.42
Diffusion-limited reaction of free nitric oxide with erythrocytes. J Biol Chem (1998) 2.66
Randomized trial of diaspirin cross-linked hemoglobin solution as an alternative to blood transfusion after cardiac surgery. The DCLHb Cardiac Surgery Trial Collaborative Group. Anesthesiology (2000) 2.41
Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin. Nat Biotechnol (1998) 2.35
The rate of oxygen uptake by human red blood cells. J Biol Chem (1979) 2.00
The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci U S A (1999) 1.99
Intravascular flow decreases erythrocyte consumption of nitric oxide. Proc Natl Acad Sci U S A (1999) 1.96
No scavenging and the hypertensive effect of hemoglobin-based blood substitutes. Free Radic Biol Med (2004) 1.96
Hemolysis-associated priapism in sickle cell disease. Blood (2005) 1.86
Effective diffusion distance of nitric oxide in the microcirculation. Am J Physiol (1998) 1.83
Diffusion of nitric oxide and scavenging by blood in the vasculature. Biochim Biophys Acta (1998) 1.81
Pulmonary hypertension and right heart failure in patients with beta-thalassemia intermedia. Chest (1995) 1.78
Erythrocytes possess an intrinsic barrier to nitric oxide consumption. J Biol Chem (2000) 1.70
Biological activity of nitric oxide in the plasmatic compartment. Proc Natl Acad Sci U S A (2004) 1.68
Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice. J Clin Invest (2004) 1.67
Impaired nitric oxide-mediated vasodilation in transgenic sickle mouse. Am J Physiol Heart Circ Physiol (2000) 1.63
Nitric oxide's reactions with hemoglobin: a view through the SNO-storm. Nat Med (2003) 1.61
Mechanisms of vascular instability in a transgenic mouse model of sickle cell disease. Am J Physiol Regul Integr Comp Physiol (2000) 1.60
Diaspirin cross-linked hemoglobin (DCLHb) in the treatment of severe traumatic hemorrhagic shock: a randomized controlled efficacy trial. JAMA (1999) 1.53
Sickle cell anemia is associated with reduced nitric oxide bioactivity in peripheral conduit and resistance vessels. Am J Hematol (2003) 1.53
Modulation of nitric oxide bioavailability by erythrocytes. Proc Natl Acad Sci U S A (2001) 1.45
Systemic and pulmonary hypertension after resuscitation with cell-free hemoglobin. J Appl Physiol (1985) (1993) 1.45
Arterial blood pressure responses to cell-free hemoglobin solutions and the reaction with nitric oxide. J Biol Chem (1998) 1.45
Haptoglobin-haemoglobin complex in human plasma inhibits endothelium dependent relaxation: evidence that endothelium derived relaxing factor acts as a local autocoid. Cardiovasc Res (1986) 1.42
Nitric oxide binding to oxygenated hemoglobin under physiological conditions. Biochim Biophys Acta (2001) 1.37
Myoglobin as a model system for designing heme protein based blood substitutes. Biophys Chem (2002) 1.36
Cardiopulmonary assessment in beta-thalassemia major. Chest (1990) 1.26
Plasma hemoglobin and hemoglobin fractions in sickle cell crisis. Am J Clin Pathol (1971) 1.23
Pulmonary hypertension in patients with thalassemia major. Am Heart J (1997) 1.22
The role of facilitated diffusion in oxygen transport by cell-free hemoglobins: implications for the design of hemoglobin-based oxygen carriers. Biophys Chem (2001) 1.20
Hemolysis in sickle cell disease. Arch Intern Med (1974) 1.19
A clinical safety trial of stroma-free hemoglobin. Clin Pharmacol Ther (1978) 1.05
alphaalpha-crosslinked hemoglobin: was failure predicted by preclinical testing? Vox Sang (2000) 1.03
Right ventricular cardiac dysfunction in beta-thalassemia major. Am J Dis Child (1987) 1.02
Pulmonary hypertension in patients with thalassemia major. Am Heart J (1999) 1.01
Acute renal failure after cardiopulmonary bypass in related to decreased serum ferritin levels. J Am Soc Nephrol (1999) 1.00
Paroxysmal nocturnal hemoglobinuria: clinical and laboratory studies relating to iron metabolism and therapy with androgen and iron. Medicine (Baltimore) (1966) 0.96
The reduction of the allogenic transfusion requirement in aortic surgery with a hemoglobin-based solution. J Vasc Surg (2000) 0.93
Impaired tissue perfusion after inhibition of endothelium-derived nitric oxide. Basic Res Cardiol (1991) 0.91
Pulmonary hypertension, interstitial lung fibrosis, and lung iron deposition in thalassaemia major. Thorax (2001) 0.90
Transient iron-overload with bleomycin-detectable iron present during cardiopulmonary bypass surgery. Free Radic Res (1994) 0.85
Inhibition of endothelium-dependent relaxation by hemoglobin in rabbit aortic strips: comparison between acellular hemoglobin derivatives and cellular hemoglobins. J Cardiovasc Pharmacol (1996) 0.85
Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution. Crit Care Med (1996) 0.84
Increased vascular resistance with hemoglobin-based oxygen carriers. Artif Cells Blood Substit Immobil Biotechnol (1994) 0.82
Hemoglobin and nitric oxide. N Engl J Med (2003) 0.82
Clinical study of totally roller pumpless cardiopulmonary bypass system. Artif Organs (1997) 0.82
Hemoglobin and nitric oxide. N Engl J Med (2003) 0.81
Silicone-coated polypropylene hollow-fiber oxygenator: experimental evaluation and preliminary clinical use. Ann Thorac Surg (1997) 0.81
Effects of temperature, oxygen, heme ligands and sulfhydryl alkylation on the reactions of nitroprusside and nitroglycerin with hemoglobin. Biochem Pharmacol (1993) 0.79
Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med (2008) 19.93
Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med (2008) 14.40
Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2009) 12.05
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes. Am J Respir Crit Care Med (2002) 10.52
Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. N Engl J Med (2004) 10.51
Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat Med (2003) 8.95
Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med (2008) 8.79
Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA (2008) 8.60
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med (2002) 7.59
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov (2008) 7.58
Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001. J Am Soc Nephrol (2006) 6.86
The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA (2005) 6.49
Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA (2005) 6.14
Sickle-cell disease. Lancet (2010) 5.64
Meta-analysis: the effect of steroids on survival and shock during sepsis depends on the dose. Ann Intern Med (2004) 5.23
Hemoglobin and the paracrine and endocrine functions of nitric oxide. N Engl J Med (2003) 4.98
Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev (2006) 4.46
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J Clin Invest (2005) 4.14
Transfusion of older stored blood and risk of death: a meta-analysis. Transfusion (2011) 3.94
Nitric oxide scavenging by red blood cell microparticles and cell-free hemoglobin as a mechanism for the red cell storage lesion. Circulation (2011) 3.81
Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J Exp Med (2007) 3.29
Large-scale proteomics and phosphoproteomics of urinary exosomes. J Am Soc Nephrol (2008) 3.22
Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control. J Clin Invest (2005) 3.08
Acute kidney injury and chronic kidney disease as interconnected syndromes. N Engl J Med (2014) 3.08
Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis. Am J Respir Crit Care Med (2002) 2.95
Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res (2007) 2.91
Excess deaths associated with tigecycline after approval based on noninferiority trials. Clin Infect Dis (2012) 2.90
The emerging biology of the nitrite anion. Nat Chem Biol (2005) 2.88
Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. J Am Coll Cardiol (2007) 2.76
Hypoxia, red blood cells, and nitrite regulate NO-dependent hypoxic vasodilation. Blood (2005) 2.76
Ceruloplasmin is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat Chem Biol (2006) 2.75
Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest (2009) 2.71
Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension. Am J Respir Crit Care Med (2007) 2.68
Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol (2009) 2.61
Bundled care for septic shock: an analysis of clinical trials. Crit Care Med (2010) 2.57
Foramen of Morgagni hernia: changes in diagnosis and treatment. Ann Thorac Surg (2004) 2.48
Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. JAMA (2005) 2.47
Major contribution of tubular secretion to creatinine clearance in mice. Kidney Int (2009) 2.46
Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation. Circulation (2007) 2.46
Discovery of protein biomarkers for renal diseases. J Am Soc Nephrol (2004) 2.43
A network model to predict the risk of death in sickle cell disease. Blood (2007) 2.39
Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome. Kidney Int (2008) 2.37
The reaction between nitrite and deoxyhemoglobin. Reassessment of reaction kinetics and stoichiometry. J Biol Chem (2005) 2.34
Surviving sepsis--practice guidelines, marketing campaigns, and Eli Lilly. N Engl J Med (2006) 2.32
Platelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. Blood (2007) 2.31
Hemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailability. Blood (2007) 2.30
Catalytic generation of N2O3 by the concerted nitrite reductase and anhydrase activity of hemoglobin. Nat Chem Biol (2007) 2.30
Nitrate and nitrite in biology, nutrition and therapeutics. Nat Chem Biol (2009) 2.29
An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease. Am J Respir Crit Care Med (2014) 2.23
Mortality increases after massive exchange transfusion with older stored blood in canines with experimental pneumonia. Blood (2012) 2.22
NO contest: nitrite versus S-nitroso-hemoglobin. Circ Res (2004) 2.21
Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica (2009) 2.20
Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc Natl Acad Sci U S A (2008) 2.17
A simplified method for HPLC determination of creatinine in mouse serum. Am J Physiol Renal Physiol (2004) 2.17
Ethyl pyruvate decreases sepsis-induced acute renal failure and multiple organ damage in aged mice. Kidney Int (2003) 2.15
Nitrite as regulator of hypoxic signaling in mammalian physiology. Med Res Rev (2009) 2.15
Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction. Circulation (2008) 2.14
The relationship between pulmonary emphysema and kidney function in smokers. Chest (2012) 2.13
Defining normal adrenal function testing in the intensive care unit setting: a canine study. Crit Care Med (2010) 2.10
Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator. Nat Med (2004) 2.09
Erythrocytes are the major intravascular storage sites of nitrite in human blood. Blood (2005) 2.08
Blood mononuclear cell gene expression profiles characterize the oxidant, hemolytic, and inflammatory stress of sickle cell disease. Blood (2004) 2.06
Measurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 2.06
Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions. Am J Hematol (2009) 2.05
N-terminal pro-brain natriuretic peptide levels and risk of death in sickle cell disease. JAMA (2006) 2.04
Separating practice guidelines from pharmaceutical marketing. Crit Care Med (2007) 2.03
Hydroxyurea induces fetal hemoglobin by the nitric oxide-dependent activation of soluble guanylyl cyclase. J Clin Invest (2003) 2.00
Divergent nitric oxide bioavailability in men and women with sickle cell disease. Circulation (2003) 1.98
Increasing evidence that the risks of rhAPC may outweigh its benefits. Intensive Care Med (2007) 1.97
Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am J Physiol Regul Integr Comp Physiol (2004) 1.97
Kidney research national dialogue overview and commentary. Clin J Am Soc Nephrol (2013) 1.96